Page 157 - CW E-Magazine (24-9-2024)

News from Abroad News from Abroad

CPHI ANNUAL REPORT 2024
CPHI report predicts biologics and ‘tides’ approvals will

surpass small molecules within the next three years

The ‘CPHI Annual Industry Survey’ projected to be the most lucrative manu- cost of monoclonal antibody (mAb)
released ahead of the leading pharma facturing over the next fi ve years. Nearly manufacturing are accelerating,
exhibition, CPHI Milan, scheduled to be 300 companies were surveyed, each with 62% identifying ‘continuous
held from October 8-10 in Milan, Italy, selecting up to two modalities. Bio- bioprocessing’ as the leading tech-
has revealed that the pharma sector is on logics (53%) and tides (43%) emerged nology to lower production costs
the cusp of a major shift, with approvals as the top choices for CDMO invest- over the next fi ve years. This far

Table-1 Table-2
Morrissey, General Manager of Gaelic offers contract manufacturing and vironmental testing, services include a
Laboratories. “Effi cient manufacturing, packaging services for a range of beta- full range of raw material testing, fi ni-
supported by an on-shoring strategy that lactams. Its beta-lactam manufacturing shed product/stability testing, analytical
enhances our supply chains and quality services include tablets, capsules, dry method validation, process and cleaning
assurance, allows the company to offer powders, blister packaging and con- validation, validation and monitoring of
competitive pricing for highest-quality tract secondary/remedial packaging. water systems, and regulatory adminis-
products,” he added. The company’s upgraded and expanded tration,” the company informed.
laboratory technology base delivers full
As well as manufacturing its own analytical testing and regulatory batch The company is also exhibiting
beta-lactam products (sold under the release services. “Focussing on micro- at ‘CPHI Milan’ scheduled to be held
Gaelic Laboratories brand) the company biology, chemical, analytical and en- from October 8 to 10.
Nominations open for ‘PCHi Fountain Awards 2025’
for complex molecules expected to out- ment, viewed as the most promising surpasses perfusion (7%) and new cell
pace those for small molecules for the areas to secure the best returns over the lines (27%), which were the primary Reed Sinopharm Exhibitions (RSE),
fi rst time. In 2023, of the 55 new drug next fi ve years. Last year’s high-ranking methods of improving yields (grams/L) the organiser of China’s personal care in-
approvals, nine were for ‘tides’ (fi ve modality, ADCs, surprisingly fi nished and reducing costs in the previous gredients expo, Personal Care and Home-
peptides and four oligonucleotides), last achieving just 15% of the vote, fi ve years. CPHI Milan is expected to care Ingredients (PCHi), has announced
with a further 17 biologics. while small molecules remained con- welcome more than 62,000 pharma that nominations for the ‘PCHi Fountain
sistent with 35%. professionals, over 2,500 exhibitors Awards 2025’ are now open. Next year’s
This shift is already infl uencing de- and more than 600 CDMOs – making edition is scheduled to be held on 19-21
cisions within the CDMO sector, with Another particularly signifi cant it by far the largest gathering in the February at the China Import and Export
biologic and tides-focused CDMOs fi nding is that efforts to reduce the contract services annual calendar. Fair Complex in Guangzhou.
EXPANDED CAPABILITIES The PCHi Fountain Awards aim to
Technology and equipment upgrades boost Gaelic recognise and reward groundbreaking

Laboratories’ capabilities products and technologies that have
signifi cantly advanced the industry. The
nominees are assessed against a rigorous
Gaelic Laboratories, the Ireland- has been producing generic medicines for across its two GMP manufacturing sites set of criteria – including product in-
based manufacturer of beta-lactam 40 years to the highest quality standards. and its testing laboratories. genuity, technical prowess, and market
(penicillin) products, is bullish on its While benefi ting from this heritage, the application prospects. All entries undergo
growth prospects after recent techno- initiation of the new company provided “Our recent technology and equip- a thorough and independent evaluation announced during the ‘PCHi Fountain step forward and showcase their ground-
logy and equipment upgrades. investment for broad-sweeping upgrades ment upgrades, and our continuing opti- by a distinguished judging committee. Awards’ ceremony on 19 February 2025. breaking work,” said a spokesperson of
across all manufacturing and testing misation of beta-lactam manufacturing “These awards represent the pinnacle of PCHi. The organiser also announced that
The company, which was established facilities. Gaelic Laboratories now hosts processes, enable us to minimise costs and The deadline for submissions is innovation in our industry, and we en- visitor pre-registration for PCHi 2025
in 2022 in Ireland, is located on a site that advanced state-of-the-art technologies improve quality,” explained Mr. Brian 22 November 2024. Winners will be courage all visionaries and pioneers to has also opened on the event’s website.

156 Chemical Weekly September 24, 2024 Chemical Weekly September 24, 2024 157

Contents Index to Advertisers Index to Products Advertised